SSRIs vs SNRIs: What Is the Difference?
Written by Dr. Daniel Duel, MD, Board-Certified Psychiatrist
SSRIs and SNRIs are both first-line antidepressants, but they work through different mechanisms and are prescribed for different reasons. Understanding the distinction can help you have a more informed conversation with your psychiatrist about which option fits your situation.
Both drug classes are widely prescribed for depression and anxiety. According to the National Institute of Mental Health, major depressive disorder affects roughly 21 million adults in the United States each year. For most of them, medication is part of the treatment picture. SSRIs and SNRIs dominate that picture because they are effective, relatively well-tolerated, and far safer in overdose than older antidepressants like tricyclics or MAOIs.
But they are not interchangeable. The right choice depends on your specific symptoms, any co-occurring conditions, how your body processes certain medications, and what side effects you can tolerate. Here is what the evidence says about each class.
What SSRIs Do
SSRI stands for selective serotonin reuptake inhibitor. These medications work by blocking the reabsorption of serotonin in the brain, leaving more of it available in the synaptic space between neurons. Serotonin is a neurotransmitter associated with mood regulation, sleep, appetite, and emotional stability.
SSRIs do not add serotonin to your brain. They slow the process by which neurons pull serotonin back in after it has been released, effectively increasing its concentration where it needs to be active.
Commonly prescribed SSRIs include:
- Fluoxetine (Prozac)
- Sertraline (Zoloft)
- Escitalopram (Lexapro)
- Citalopram (Celexa)
- Paroxetine (Paxil)
- Fluvoxamine (Luvox)
SSRIs are generally considered the starting point for treating major depressive disorder, generalized anxiety disorder, panic disorder, social anxiety disorder, OCD, and PTSD. Fluoxetine is also FDA-approved for bulimia nervosa and is one of the few antidepressants approved for use in children and adolescents.
What SNRIs Do
SNRI stands for serotonin-norepinephrine reuptake inhibitor. These medications block the reuptake of both serotonin and norepinephrine. Norepinephrine is a neurotransmitter that plays a role in alertness, energy, concentration, and the body’s stress response. It is also involved in pain signaling.
The addition of norepinephrine activity is what primarily separates SNRIs from SSRIs. That second mechanism matters in clinical practice. Patients who have not responded fully to an SSRI sometimes do better on an SNRI, particularly when fatigue, low motivation, or physical pain are prominent symptoms alongside depression.
Commonly prescribed SNRIs include:
- Venlafaxine (Effexor XR)
- Duloxetine (Cymbalta)
- Desvenlafaxine (Pristiq)
- Levomilnacipran (Fetzima)
- Milnacipran (Savella) is approved for fibromyalgia, sometimes used off-label for depression.
Duloxetine in particular has FDA approval not only for depression and anxiety but also for diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain. For patients dealing with both mood symptoms and chronic pain, an SNRI may serve double duty in a way an SSRI cannot.
Patients experiencing fatigue, difficulty concentrating, or low motivation alongside depression may find that SNRIs, with their norepinephrine activity, address those symptoms more directly. This is why many psychiatrists reach for an SNRI when a patient describes depression that feels more like “I can’t get off the couch” than “I feel sad all the time.”
For a deeper look at how these medications are used in treating depressive disorders, the full condition overview at PsychBright Health covers subtypes, diagnostic criteria, and treatment approaches for depressive disorders and mood conditions.
How SSRIs and SNRIs Compare: A Side-by-Side Look
| Feature | SSRIs | SNRIs |
|---|---|---|
| Mechanism | Blocks serotonin reuptake only | Blocks serotonin and norepinephrine reuptake |
| Primary uses | Depression, anxiety, OCD, PTSD, panic disorder | Depression, anxiety, chronic pain, fibromyalgia, neuropathy |
| Common examples | Sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac) | Venlafaxine (Effexor XR), duloxetine (Cymbalta), desvenlafaxine (Pristiq) |
| Useful when | First-line for most mood and anxiety disorders; generally well tolerated | Depression with fatigue, low motivation, or co-occurring pain conditions |
| Blood pressure effects | Minimal | Higher doses of SNRIs can raise blood pressure; monitoring recommended |
| Discontinuation syndrome | Varies; paroxetine and venlafaxine carry a higher risk | Venlafaxine has a notably high discontinuation risk; taper slowly |
| Sexual side effects | Common (affects 40-65% of patients) | Common; similar rate to SSRIs |
| Approved for chronic pain | No | Yes (duloxetine, milnacipran) |
Side Effects: Where They Overlap and Where They Differ
Both classes share a common side effect profile in many ways. The first two weeks on either medication often bring nausea, headache, mild insomnia, and increased anxiety before the therapeutic effect kicks in. This initial worsening of anxiety is one of the most common reasons patients stop early. If your psychiatrist starts you on a low dose and increases gradually, that window is usually manageable.
Sexual side effects are a real and frequently underdiscussed problem with both SSRIs and SNRIs. Decreased libido, delayed orgasm, and erectile dysfunction affect a significant percentage of patients on these medications. If sexual side effects are a concern going in, there are alternatives worth discussing, including bupropion (Wellbutrin), which works on dopamine and norepinephrine and has a much lower rate of sexual side effects.
Where SNRIs diverge from SSRIs on the side effect front:
- Blood pressure: Norepinephrine activity can raise blood pressure, particularly at higher doses of venlafaxine. Patients with pre-existing hypertension need closer monitoring on an SNRI.
- Discontinuation syndrome: Stopping venlafaxine too quickly can produce intense withdrawal-like symptoms, including brain zaps, dizziness, flu-like feelings, and mood swings. This is not dangerous but is deeply uncomfortable. Slow tapers over weeks or months are standard practice.
- Sweating: SNRIs tend to cause more excessive sweating than SSRIs, which some patients find bothersome enough to switch medications.
Which One Should You Take?
No general article can answer this for any individual patient. What it can do is frame the question you should be asking your psychiatrist.
SSRIs are typically the first prescription written for depression or anxiety in someone who has not tried antidepressants before. They have decades of safety data, the side effect profile is well-characterized, and most patients tolerate them without significant problems. Sertraline and escitalopram consistently rank among the most prescribed and best-tolerated options in head-to-head studies.
Your psychiatrist may lean toward an SNRI if you have tried an SSRI without a full response, if fatigue and motivation problems are prominent, or if you are also dealing with chronic pain. Duloxetine is a frequent choice when depression overlaps with a physical pain condition, because a single medication can address both.
The decision also involves your personal history. Some people metabolize certain medications faster or slower based on their genetics. Variations in cytochrome P450 enzymes can affect how SSRIs like fluoxetine and paroxetine are metabolized and can lead to drug-drug interactions. Pharmacogenomic testing is increasingly available and can inform these choices before you go through months of trial and error.
Cost and insurance coverage matter too. Most SSRIs and SNRIs are available as generics at very low cost. Brand-name versions may have specific formulations that matter in some cases, but generic sertraline, escitalopram, venlafaxine, and duloxetine are all widely available.
How Long Before You Feel the Effect?
Both SSRIs and SNRIs typically take two to six weeks before a meaningful reduction in symptoms occurs. Full therapeutic effect often takes eight to twelve weeks. This is one of the hardest parts of starting antidepressant therapy: you feel the side effects immediately, and the benefit comes later.
If you are not seeing improvement by six to eight weeks at an adequate dose, that is the signal to reassess, not the signal to give up on medication entirely. A psychiatrist may adjust the dose, switch to a different medication in the same class, or add a second agent. A non-response to one SSRI does not predict non-response to another. And a non-response to SSRIs overall does not predict how you will respond to an SNRI.
A Note on Self-Prescribing and Online Platforms
SSRIs in particular have become widely prescribed through telehealth platforms over the past several years. That accessibility has helped many people who would not otherwise have sought care. The concern worth noting is that the initial prescription is only part of the picture. Ongoing follow-up, dose adjustment, managing side effects, and recognizing when a different medication is a better fit require a psychiatrist with full clinical context and time to engage with each patient individually.
Platforms that use algorithms to match patients with providers and offer limited appointment times are not well-positioned to manage the complexity of treatment-resistant depression or cases where a co-occurring condition like ADHD, bipolar disorder, or a substance use disorder is affecting the picture. These are exactly the cases where a board-certified psychiatrist makes the biggest difference.
The National Institute of Mental Health’s medication resource is a reliable starting point for evidence-based information on antidepressants and how they are evaluated.
Frequently Asked Questions
Can I switch from an SSRI to an SNRI?
Yes, switching between these two classes is common and generally manageable under psychiatric supervision. The transition approach depends on which medications are involved. Some switches require a washout period, while others can be done with a cross-taper where one medication is gradually reduced as the other is introduced. Venlafaxine in particular requires careful dose titration when starting, so an abrupt switch without a plan is not advisable. Your psychiatrist will determine the safest approach based on the specific medications and your current clinical state.
Are SNRIs stronger than SSRIs?
“Stronger” is not the right frame. SNRIs act on an additional neurotransmitter pathway, which makes them useful for certain symptom profiles, particularly fatigue, motivation deficits, and co-occurring pain, but that does not make them universally more effective for depression or anxiety. In head-to-head trials, SSRIs and SNRIs show comparable efficacy for most mood and anxiety disorders. The better question is which class is better suited to your specific symptoms, history, and any co-occurring conditions. A psychiatrist can work through that with you based on your full clinical picture.
What happens if I stop taking an SSRI or SNRI suddenly?
Stopping either class abruptly without tapering can produce discontinuation syndrome. Symptoms include dizziness, nausea, flu-like feelings, irritability, vivid dreams, and what patients often describe as brain zaps, brief electrical-like sensations in the head. These are not dangerous but can be genuinely disruptive. Venlafaxine and paroxetine are associated with the most severe discontinuation reactions among this drug class. The standard approach is a gradual dose reduction over weeks or months, depending on how long you have been on the medication and at what dose. Never stop an antidepressant without talking to your prescriber first.
Can SSRIs or SNRIs treat anxiety as well as depression?
Yes. Both classes are FDA-approved for multiple anxiety disorders, not just depression. SSRIs are first-line treatments for generalized anxiety disorder, social anxiety disorder, panic disorder, PTSD, and OCD. SNRIs, including venlafaxine and duloxetine, also have FDA approval for generalized anxiety disorder, social anxiety disorder, and panic disorder. In clinical practice, many patients present with both depressive and anxiety symptoms simultaneously, and a single medication from either class often addresses both. The choice between them for anxiety-dominant presentations follows the same logic as for depression; symptom profile, tolerance, and individual response guide the decision.
Do SSRIs and SNRIs cause weight gain?
Weight changes are possible with both classes, though the effect varies considerably by individual and by specific medication. Paroxetine (Paxil) has the strongest association with weight gain among the SSRIs. Fluoxetine (Prozac) is sometimes weight-neutral or associated with mild initial weight loss. SNRIs like duloxetine and venlafaxine can cause modest weight changes in either direction. For patients where weight is a significant concern, this is an important factor to raise with your psychiatrist before starting, because there are medication options with lower weight gain profiles. Weight changes on antidepressants are also influenced by whether the medication is improving sleep and appetite, which were themselves disrupted by the depression.
How do I know if my antidepressant is working?
Look for changes in sleep, appetite, and energy first. These often improve before mood lifts, typically within two to four weeks. Mood improvement typically follows at the four to eight week mark. A meaningful response means a noticeable reduction in the frequency and intensity of symptoms, not necessarily their complete absence. Your psychiatrist should use a standardized rating scale like the PHQ-9 to track progress at follow-up visits. If you are not seeing any improvement by six to eight weeks at an adequate dose, that is the time to reassess the medication choice, dose, or whether an additional evaluation is warranted.
PsychBright Health evaluates patients for depression, anxiety, and other mood disorders and can prescribe SSRIs, SNRIs, or other medications based on a full psychiatric evaluation. Appointments are available within five business days, and the practice accepts Aetna, Blue Shield, UHC, Cigna, Anthem, Medicare, and Medicare Advantage. If you are ready to talk to a board-certified psychiatrist about your options, reach out at psychbrighthealth.com/contact or call (213) 584-2331.
PsychBright Health
1180 S Beverly Dr #700
Los Angeles, CA 90035
Phone: (213) 584-2331
Monday-Friday, 8 am-5 pm
Serving Los Angeles, West Hollywood, Beverly Hills, Santa Monica, Culver City, Brentwood, and all of California via telehealth.